ClinicalTrials.gov record
ABT-450 With Ritonavir and ABT-267 and/or ABT-333 With and Without Ribavirin in Genotype 1 Hepatitis C Virus Infected Patients
ClinicalTrials.gov ID: NCT01464827
Public ClinicalTrials.gov record NCT01464827. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Open-Label, Multicenter Study to Evaluate the Antiviral Activity, Safety, and Pharmacokinetics, of ABT-450 With Ritonavir (ABT-450/r) in Combination With ABT-267 and/or ABT-333 With and Without Ribavirin (RBV) for 8, 12 or 24 Weeks in Treatment-Naïve and Null Responder Subjects With Genotype 1 Chronic Hepatitis C Virus Infection
Study identification
- NCT ID
- NCT01464827
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- AbbVie (prior sponsor, Abbott)
- Industry
- Enrollment
- 580 participants
Conditions and interventions
Interventions
- ABT-450 Drug
- ABT-333 Drug
- ABT-267 Drug
- Ribavirin Drug
- Ritonavir Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 30, 2011
- Primary completion
- Feb 28, 2013
- Completion
- Aug 31, 2013
- Last update posted
- Apr 21, 2015
2011 – 2013
United States locations
- U.S. sites
- 60
- U.S. states
- 27
- U.S. cities
- 55
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site Reference ID/Investigator# 57583 | Birmingham | Alabama | 35209 | — |
| Site Reference ID/Investigator# 55530 | Birmingham | Alabama | 35215 | — |
| Site Reference ID/Investigator# 55385 | Dothan | Alabama | 36305 | — |
| Site Reference ID/Investigator# 55500 | Phoenix | Arizona | 85054 | — |
| Site Reference ID/Investigator# 55382 | Tucson | Arizona | 85724 | — |
| Site Reference ID/Investigator# 61042 | Bakersfield | California | 93301 | — |
| Site Reference ID/Investigator# 43651 | Coronado | California | 92118 | — |
| Site Reference ID/Investigator# 43652 | Costa Mesa | California | 92626 | — |
| Site Reference ID/Investigator# 59130 | Los Angeles | California | 90048 | — |
| Site Reference ID/Investigator# 43565 | San Diego | California | 92123 | — |
| Site Reference ID/Investigator# 43910 | Aurora | Colorado | 80045 | — |
| Site Reference ID/Investigator# 43572 | Bradenton | Florida | 34209 | — |
| Site Reference ID/Investigator# 43584 | Ft. Pierce | Florida | 34982 | — |
| Site Reference ID/Investigator# 43917 | Gainesville | Florida | 32610 | — |
| Site Reference ID/Investigator# 55384 | Jacksonville | Florida | 32256 | — |
| Site Reference ID/Investigator# 44610 | Wellington | Florida | 33414 | — |
| Site Reference ID/Investigator# 55531 | Wellington | Florida | 33414 | — |
| Site Reference ID/Investigator# 55536 | Zephyrhills | Florida | 33542 | — |
| Site Reference ID/Investigator# 55540 | Macon | Georgia | 31201 | — |
| Site Reference ID/Investigator# 55527 | Marietta | Georgia | 30060 | — |
| Site Reference ID/Investigator# 44621 | Chicago | Illinois | 60637 | — |
| Site Reference ID/Investigator# 43576 | Indianapolis | Indiana | 46202-5121 | — |
| Site Reference ID/Investigator# 55383 | Bowling Green | Kentucky | 42101 | — |
| Site Reference ID/Investigator# 59124 | Shreveport | Louisiana | 71105 | — |
| Site Reference ID/Investigator# 43568 | Annapolis | Maryland | 21401 | — |
| Site Reference ID/Investigator# 55901 | Baltimore | Maryland | 21201 | — |
| Site Reference ID/Investigator# 43588 | Lutherville | Maryland | 21093 | — |
| Site Reference ID/Investigator# 55534 | Boston | Massachusetts | 02215 | — |
| Site Reference ID/Investigator# 43656 | Springfield | Massachusetts | 01105 | — |
| Site Reference ID/Investigator# 43655 | Ann Arbor | Michigan | 48109-0848 | — |
| Site Reference ID/Investigator# 43913 | Detroit | Michigan | 48202 | — |
| Site Reference ID/Investigator# 43587 | Saint Paul | Minnesota | 55114 | — |
| Site Reference ID/Investigator# 43661 | Jackson | Mississippi | 39202 | — |
| Site Reference ID/Investigator# 43569 | Kansas City | Missouri | 64131 | — |
| Site Reference ID/Investigator# 44608 | St Louis | Missouri | 63104 | — |
| Site Reference ID/Investigator# 55526 | Egg Harbor | New Jersey | 08234 | — |
| Site Reference ID/Investigator# 43566 | Manhasset | New York | 11030 | — |
| Site Reference ID/Investigator# 59133 | Monticello | New York | 12701 | — |
| Site Reference ID/Investigator# 43586 | New York | New York | 10016 | — |
| Site Reference ID/Investigator# 43573 | New York | New York | 10021 | — |
| Site Reference ID/Investigator# 55532 | Poughkeepsie | New York | 12601 | — |
| Site Reference ID/Investigator# 55386 | Rochester | New York | 14625 | — |
| Site Reference ID/Investigator# 55538 | Charlotte | North Carolina | 28207 | — |
| Site Reference ID/Investigator# 55522 | Fayetteville | North Carolina | 28304 | — |
| Site Reference ID/Investigator# 55542 | Statesville | North Carolina | 28677 | — |
| Site Reference ID/Investigator# 55533 | Cincinnati | Ohio | 45242 | — |
| Site Reference ID/Investigator# 43665 | Cincinnati | Ohio | 45267-0595 | — |
| Site Reference ID/Investigator# 43585 | Medford | Oregon | 97504 | — |
| Site Reference ID/Investigator# 55539 | Portland | Oregon | 97225 | — |
| Site Reference ID/Investigator# 56622 | Philadelphia | Pennsylvania | 19106 | — |
| Site Reference ID/Investigator# 43592 | Germantown | Tennessee | 38138 | — |
| Site Reference ID/Investigator# 55723 | Germantown | Tennessee | 38138 | — |
| Site Reference ID/Investigator# 43659 | Nashville | Tennessee | 37203 | — |
| Site Reference ID/Investigator# 59132 | Houston | Texas | 77005 | — |
| Site Reference ID/Investigator# 43577 | San Antonio | Texas | 78215 | — |
| Site Reference ID/Investigator# 43662 | Annandale | Virginia | 22003 | — |
| Site Reference ID/Investigator# 43666 | Newport News | Virginia | 23602 | — |
| Site Reference ID/Investigator# 43574 | Seattle | Washington | 98101 | — |
| Site Reference ID/Investigator# 43578 | Madison | Wisconsin | 53792-5124 | — |
| Site Reference ID/Investigator# 55387 | Milwaukee | Wisconsin | 53215 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 37 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01464827, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 21, 2015 · Synced Jun 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01464827 live on ClinicalTrials.gov.